Who is leading the uptake of weight loss injections in the UK?

Women and individuals from middle-class backgrounds are dominating the uptake of private prescriptions for weight loss injections.

Are weight loss injections equally accessible across different regions in the UK?

No, people in the most deprived regions are significantly less likely to access these drugs compared to those in less deprived areas, despite higher obesity rates.

When do people in deprived areas typically start weight loss treatment?

Individuals in more deprived areas tend to start weight loss treatment later, often at higher BMIs, indicating delayed access.

Home / Health / Obesity Drugs Fueling Class Divide: Study

Obesity Drugs Fueling Class Divide: Study

18 Feb

•

Summary

Women disproportionately use weight loss injections.
Deprived areas see less uptake despite higher obesity.
Treatment access shows significant inequality in UK.

Obesity Drugs Fueling Class Divide: Study

Analysis of private weight loss injection prescriptions indicates a significant divide in access, with women and the middle classes leading uptake. Glucagon-like peptide-1 receptor agonists (GLP-1s), which mimic natural hormones to promote fullness, are largely prescribed privately due to phased NHS rollouts. Research indicates people in the most deprived regions are about a third less likely to access these drugs compared to those in less deprived areas, despite higher obesity levels.

Furthermore, individuals in more deprived areas tend to begin treatment at higher BMIs, suggesting delayed access and increased health risks. While the NHS is prioritizing rollout for those with significant clinical need, current data implies even eligible patients face barriers. The findings underscore the need for fair public provision and continued focus on preventative measures against obesity.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.